Supplementary materials and methods from Allogeneic Human Double Negative T Cells as a Novel Immunotherapy for Acute Myeloid Leukemia and Its Underlying Mechanisms
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)